US: A deadly parasite known to cause illness in pregnant women and immunocompromised patients could potentially be used to treat various types of tumours, according to a new study. The study's findings were published in the journal 'Journal for ImmunoTherapy Cancer.'
The Researches from the University of Nottingham, Ningbo University, and Shanxi Agricultural University in China conducted the study. To beat certain cancers, stop tumour progression, and extend patients' lives, it's critical to improve the effectiveness of treatments against specific types of tumours. In this new study, researchers discovered that a parasite found all over the world can sensitise cold tumours to immune checkpoint blockade therapy. Cold tumours are tumours that are unlikely to elicit a strong immune response from the body.
The researchers believe that this discovery could have broader therapeutic implications for a variety of cancers. The researchers were able to tame Toxoplasma gondii, a single-celled opportunistic protozoan that can infect a wide range of warm-blooded animals and has been found in nearly one-third of the world's human population.
Study shows COVID-19 infection is less severe thanks to a new antibody
Zika Virus Patient goes through Treatment In UP's Kanpur, 22 Samples Test Negative
Study reveals Aerosols spread tuberculosis like Covid-19